3/31
07:20 am
antx
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease [Yahoo! Finance]
Low
Report
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease [Yahoo! Finance]
3/31
07:00 am
antx
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease
Medium
Report
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease
3/17
04:42 pm
antx
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
Medium
Report
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
3/17
04:00 pm
antx
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
Medium
Report
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
3/9
08:12 am
antx
AN2 Therapeutics raises $40M privately [Seeking Alpha]
High
Report
AN2 Therapeutics raises $40M privately [Seeking Alpha]
3/9
07:03 am
antx
AN2 Therapeutics Announces $40 Million Private Placement Financing [Yahoo! Finance]
High
Report
AN2 Therapeutics Announces $40 Million Private Placement Financing [Yahoo! Finance]
3/9
07:00 am
antx
AN2 Therapeutics Announces $40 Million Private Placement Financing
High
Report
AN2 Therapeutics Announces $40 Million Private Placement Financing
3/3
04:11 pm
antx
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) [Yahoo! Finance]
High
Report
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) [Yahoo! Finance]
5/13/2025
04:01 pm
antx
an2 therapeutics, inc.
MISS
Report
0.8%
an2 therapeutics, inc.
3/25
04:42 pm
antx
Form D AN2 Therapeutics, Inc.
Low
Report
Form D AN2 Therapeutics, Inc.
3/23
07:17 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Day Lucy
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Day Lucy
3/23
07:16 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Chanda Sanjay
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Chanda Sanjay
3/23
07:14 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Marks Gilbert Lynn
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Marks Gilbert Lynn
3/23
07:11 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Aziz Kabeer
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Aziz Kabeer
3/23
07:10 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Martin Patricia A.
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Martin Patricia A.
3/23
07:10 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: FitzPatrick Margaret M
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: FitzPatrick Margaret M
3/23
07:08 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Wong Stephanie
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Wong Stephanie
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register